Mutant superoxide dismutase 1-induced IL-1β accelerates ALS pathogenesis

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 29, 2010, Pages 13046-13050

  Meissner, Felix ^a   Molawi, Kaaweh ^a   Zychlinsky, Arturo ^a  

^a MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

Caspase 1; Inflammasome; Interleukin 1; Lou gehrig's disease; Neurodegeneration

Indexed keywords

AMYLOID; COPPER ZINC SUPEROXIDE DISMUTASE; INFLAMMASOME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; DISEASE COURSE; ENZYME ACTIVATION; MICROGLIA; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING;

AMINO ACID SUBSTITUTION; AMYLOID; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AUTOPHAGY; CASPASE 1; CYTOPLASM; DISEASE PROGRESSION; ENZYME ACTIVATION; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1BETA; MICE; MICROGLIA; MUTANT PROTEINS; PROTEIN CONFORMATION; PROTEIN FOLDING; SUPEROXIDE DISMUTASE;

MUS MUSCULUS;

EID: 77955649302     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1002396107     Document Type: Article

References (28)

1. Rothstein JD (2009) Current hypotheses for the underlying biology of amyotrophic lateral sclerosis. Ann Neurol 65(Suppl 1):S3-S9.
2. Ilieva H, Polymenidou M, Cleveland DW (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 187:761-772.
3. Chattopadhyay M, Valentine JS (2009) Aggregation of copper-zinc superoxide dismutase in familial and sporadic ALS. Antioxid Redox Signal 11:1603-1614.
4. McGeer PL, McGeer EG (2002) Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve 26:459-470.
5. Halle A, et al. (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857-865.
6. Pasinelli P, Houseweart MK, Brown RH, Jr, Cleveland DW (2000) Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 97:13901-13906.
7. Li M, et al. (2000) Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288:335-339. (Pubitemid 30226195)
8. Lamkanfi M, Dixit VM (2009) Inflammasomes: Guardians of cytosolic sanctity. Immunol Rev 227:95-105.
9. Urushitani M, et al. (2006) Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat Neurosci 9:108-118. (Pubitemid 43011916)
10. Zhao W, et al. (2010) Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia 58:231-243.
11. Hornung V, et al. (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9:847-856.
12. Levine B, Deretic V (2007) Unveiling the roles of autophagy in innate and adaptive immunity. Nat Rev Immunol 7:767-777. (Pubitemid 47480305)
13. Hetz C, et al. (2009) XBP-1 deficiency in the nervous system protects against amyotrophic lateral sclerosis by increasing autophagy. Genes Dev 23:2294-2306.
14. Kuma A, et al. (2004) The role of autophagy during the early neonatal starvation period. Nature 432:1032-1036. (Pubitemid 40052234)
15. Gurney ME, et al. (1994) Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 264:1772-1775. (Pubitemid 24227760)
16. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-550.
17. Nguyen MD, Julien JP, Rivest S (2001) Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann Neurol 50:630-639.
18. Hensley K, et al. (2006) Primary glia expressing the G93A-SOD1 mutation present a neuroinflammatory phenotype and provide a cellular system for studies of glial inflammation. J Neuroinflammation 3:2-10.
19. Bruijn LI, et al. (1997) ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18:327-338.
20. Rakhit R, et al. (2007) An immunological epitope selective for pathological monomer-misfolded SOD1 in ALS. Nat Med 13:754-759.
21. Zetterström P, et al. (2007) Soluble misfolded subfractions of mutant superoxide dismutase-1s are enriched in spinal cords throughout life in murine ALS models. Proc Natl Acad Sci USA 104:14157-14162.
22. Prudencio M, Hart PJ, Borchelt DR, Andersen PM (2009) Variation in aggregation propensities among ALS-associated variants of SOD1: Correlation to human disease. Hum Mol Genet 18:3217-3226.
23. Stewart CR, et al. (2010) CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol 11:155-161.
24. Tükel C, et al. (2009) Responses to amyloids of microbial and host origin are mediated through toll-like receptor 2. Cell Host Microbe 6:45-53.
25. Friedlander RM (2000) Role of caspase 1 in neurologic disease. Arch Neurol 57:1273-1276.
26. Moisse K, Strong MJ (2006) Innate immunity in amyotrophic lateral sclerosis. Biochim Biophys Acta 1762:1083-1093.
27. Hall ED, Oostveen JA, Gurney ME (1998) Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. Glia 23:249-256.
28. Habisch HJ, et al. (2007) Intrathecal application of neuroectodermally converted stem cells into a mouse model of ALS: Limited intraparenchymal migration and survival narrows therapeutic effects. J Neural Transm 114:1395-1406.